{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":22,"n_cols":5,"rows_kept":22,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[12,2,12,3],[15,2,15,3],[16,2,16,3],[20,2,20,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNISA996206954403316"]
[null,null,"Titolo",null,"Fetal antigens and cancer / / [editors: David Evered (organizer) and Julie Whelan]"]
[null,null,"Pubbl/distr/stampa",null,"London, : Pitman"]
[{"$nulls":4},"Summit, N.J., : distributed in North America by CIBA Pharmaceutical, 1983"]
[null,null,"ISBN",null,"1-280-78401-6"]
[{"$nulls":4},"9786613694409"]
[{"$nulls":4},"0-470-72077-8"]
[{"$nulls":4},"0-470-71847-1"]
[null,null,"Descrizione fisica",null,"1 online resource (274 pages) : illustrations"]
[null,null,"Collana",null,"Ciba Foundation symposium ; ; 96"]
[null,null,"Disciplina",null,"616.99/40792"]
[{"$nulls":4},"616.9940792"]
[null,null,"Soggetti",null,"Fetus - Cancer"]
[{"$nulls":4},"Cancer - Immunological aspects"]
[{"$nulls":4},"Tumor antigens"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","\"Symposium on Fetal antigens and cancer, held at the Ciba Foundation, London, 20-22 July 1982\"--Contents page."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and indexes."]
[null,null,"Nota di contenuto",null,"Fetal antigens and cancer; Contents; Introduction; Expression of embryonic characters by malignant cells; Discussion; Embryonic antigens in malignancy and pregnancy: common denominators in immune regulation; Discussion; The T/t-complex: a family of genes controlling early embryonic surface antigens; Discussion; Fetal histocompatibility antigens and maternal immune responses; Discussion; How are tumour antigens related to normal antigens?; Discussion; The functional significance of tumour-associated cell surface alterations of embryonic and unknown origin; Discussion"]
[{"$nulls":4},"Host recognition of antigens: do they induce specific antibodies? Discussion; Human chorionic gonadotropin as a model for a fetal antigen; Discussion; Can fetal antigens be used for prophylactic immunization?; Discussion; Parity and susceptibility to cancer; Discussion; Embryonic precancerous and cancerous human antigens recognized by monoclonal antibodies; Discussion; Antibodies to fetal antigens associated with rodent tumours; Discussion; General discussion; Closing remarks; Index of contributors; Subject index"]